slides · global inventory
11 Golden Circle
Loop collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 13,983
Current window 9,691-9,720
Pages 467
Rows per page 30
Loop
9,691-9,720 of 13,983
11
The slide uses QR codes to link to specific research papers (Shanehsazzadeh et al. 2023, Constant et al. 2023, Bachas et al. 2022).Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Call to AdventureLoop · Golden Circle1 hit
12
The slide uses a linear process flow with icons representing AI intervention at each stage.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations Beat · Call to AdventureLoop · Golden Circle1 hit
07
The slide uses a metaphor to frame the company's value proposition against the backdrop of low clinical trial success rates.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
08
The slide uses a flywheel-style diagram to represent the iterative nature of the platform.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Solution & ApproachLoop · Golden Circle1 hit
06
The slide uses a three-column layout to present distinct technological approaches.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
07
The chart uses a horizontal bar representation to indicate progress through discovery and IND-enabling stages.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
08
The slide features a stylized antibody graphic overlaid on a dark blue/purple abstract background.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
09
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
10
The slide uses a structural biology visualization and two dose-response curves to establish bio-equivalence and differentiation.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
11
The slide uses two semi-logarithmic line charts to compare drug concentration decay over time.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
13
The slide uses a stepped process diagram to illustrate dose escalation cohorts.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
14
The slide uses a comparative bar chart approach to justify the human half-life prediction based on NHP data.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
15
Uses icon-based visualization to represent injection frequency.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
16
The slide uses a combination of a pharmacokinetic simulation line chart and a bar chart showing clinical remission rates by exposure quartile.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
17
The slide uses a timeline-like visual to compare dosing schedules at weeks 0, 2, and 6.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
18
The slide uses a comparative table for safety metrics and a bar chart for ADA rates to establish clinical equivalence/safety.Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
19
Aeglea BioTherapeutics | Investor Presentation Deck | 37 slidesAeglea BioTherapeutics | Investor Presentation Deck | 37 slides · Spyre Therapeutics
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
03
The slide features a personal narrative and a photo of the director on set.AKT Pictures | Other Presentation Deck | 17 slides · akt-pictures
Deck Investor relations Beat · Ordinary WorldLoop · Golden Circle1 hit
04
The slide uses a movie still (likely from 'Clueless') to illustrate the narrative.AKT Pictures | Other Presentation Deck | 17 slides · akt-pictures
Deck Investor relations Beat · Ordinary WorldLoop · Golden Circle1 hit
05
The slide uses a split-image layout to define the film's visual world-building.AKT Pictures | Other Presentation Deck | 17 slides · akt-pictures
Deck Investor relations Beat · Ordinary WorldLoop · Golden Circle1 hit
11
The slide uses a donut chart to show revenue composition and highlights global reach.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · Business ModelLoop · Golden Circle1 hit
12
The central diagram is a complex network graph connecting six strategic pillars to a central hub.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Loop · Golden Circle1 hit
13
The slide uses a grid layout to present distinct business growth levers.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Loop · Golden Circle1 hit
14
The slide uses a grid of metrics to present financial performance.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · FinancialsLoop · Golden Circle1 hit
15
Includes disclaimer regarding the date of guidance and growth rate context.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · FinancialsLoop · Golden Circle1 hit
16
The slide uses a three-column layout to categorize the merger benefits.Orthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · FinancialsLoop · Golden Circle1 hit
17
Orthofix | Investor Presentation Deck | 22 slidesOrthofix | Investor Presentation Deck | 22 slides · Orthofix
Pitch deck Investor relations Beat · FinancialsLoop · Golden Circle1 hit
03
Pathward Financial | Investor Presentation Deck | 23 slidesPathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · ProblemLoop · Golden Circle1 hit
04
The timeline shows a transition from a traditional savings and loan bank to a diversified financial services company focused on BaaS and national banking.Pathward Financial | Investor Presentation Deck | 23 slides · Pathward
Pitch deck Investor relations Beat · ProblemLoop · Golden Circle1 hit